Related Experiment Video
Updated: Sep 16, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
A microprotein atlas of the human frontal cortex in Alzheimer's disease
Brendan Miller1, Eduardo Vieira de Souza2, Calvin Lau2
1Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies, La Jolla, CA, USA. brmiller@salk.edu.
Abstract:
Understanding the molecular basis of neurodegeneration requires a comprehensive map of the genome's protein-coding output. Although thousands of small open reading frames (ORFs) are translated in the human brain, proteomic evidence for their encoded microproteins (MPs) (≤150 amino acids (aa)) remains limited. Here, we present a brain MP atlas that integrates transcriptomics, mass spectrometry and deep-learning-predicted spectra across more than 600 postmortem frontal cortex samples with and without Alzheimer's disease (AD). We identified 1,067 MPs absent from reviewed UniProtKB entries with high-confidence spectral support. A subset is differentially expressed in AD independently of the annotated main ORF at the same locus. A small ORF expressed by MKKS encodes a 63-amino-acid MP that is the locus's predominant translation product and is downregulated in AD; its loss impairs microglial mitochondrial respiration, implicating it in microglial bioenergetics. This atlas expands the annotated brain proteome and provides a resource for studying MPs in aging and neurodegeneration.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
